Daniel D. Burton, Chief Executive Officer at Health Catalyst, Inc. (HCAT), sold 281,816 shares at $30.98 ($8.7M) on 2020-06-25, disclosed to the SEC on 2020-06-29.
Open-market sale of $8.7M HCAT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.98 | 104,662 | $3.2M | 37.2% |
| 2 | $30.98 | 104,662 | $3.2M | 37.2% |
| 3 | $31.53 | 8,924 | $281K | 3.2% |
| 4 | $31.53 | 8,924 | $281K | 3.2% |
| 5 | $31.53 | 2,883 | $91K | 1.0% |
| 6 | $31.53 | 2,883 |
| $91K |
| 1.0% |
| 7 | $30.25 | 24,439 | $739K | 8.5% |
| 8 | $30.25 | 24,439 | $739K | 8.5% |
| Total | $30.90 avg | 281,816 | $8.7M | 100% |
| Filing → |
| HCAT | BUY | 2022-11-14 | $4.0M | — | Filing → |
| HCAT | BUY | 2022-09-08 | $2.0M | — | Filing → |
| HCAT | BUY | 2022-08-09 | $4.1M | — | Filing → |